Didier Laurent - Concepedia

Author

Didier Laurent

Also Known As

D LAURENT, D Laurent, D. LAURENT, D. Laurent, DIDIER LAURENT, Didier Laurent, Jérome Amathieu, Laurent D., Laurent, D, Laurent, D.D.

135

Publications

7.3K

Citations

H-Index

118

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research Novartis (United States)Yale University Howard Hughes Medical Institute

About

Didier Laurent is an author at Novartis (Switzerland) specializing in medicine, health sciences, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	2.2K
2	Health Sciences	16	19	1.6K
3	Engineering	4	4	126
4	Social Sciences	1	1	11
5	Allergy	1	1	12

Didier Laurent

Publications

Citations

H-Index

Page 1

	Year	Citations
Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity Alan Dresner, Didier Laurent, Melissa Marcucci, Journal of Clinical Investigation	1999	1.3K
Mechanism by which metformin reduces glucose production in type 2 diabetes. Ripudaman S. Hundal, Martin Krššák, Sylvie Dufour, Diabetes	2000	1K
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial Dominique Baeten, Xenofon Baraliakos, Jürgen Braun, The Lancet InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseMedicine	2013	585
Effects of Pioglitazone on Adipose Tissue Remodeling Within the Setting of Obesity and Insulin Resistance Christopher J. de Souza, Michele Eckhardt, Karen Gagen, Diabetes Metabolic DisorderMetabolic RemodelingInsulin SignalingMagnetic Resonance ImagingObesity	2001	346
Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia Matteo Cesari, Roger A. Fielding, Marco Pahor, Journal of Cachexia Sarcopenia and Muscle Muscle FunctionKinesiologyAgingHealth SciencesGeriatrics	2012	289
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity Steven B. Heymsfield, Laura A. Coleman, Ram R. Miller, JAMA Network Open	2021	259
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. Kitt Falk Petersen, Didier Laurent, Douglas L. Rothman, Journal of Clinical Investigation Insulin SignalingMetabolic SyndromeMetabolic SignalingMetabolic StateExtensive Glycogen Cycling	1998	233
Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study Daniel Rooks, Jens Præstgaard, Sam Hariry, Journal of the American Geriatrics Society	2017	215
Treatment of sporadic inclusion body myositis with bimagrumab Anthony A. Amato, Kumaraswamy Sivakumar, Namita Goyal, Neurology	2014	195
Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13C and 1H Nuclear Magnetic Resonance Spectroscopy Study1 Martin Krššák, Kitt Falk Petersen, Raynald Bergeron, The Journal of Clinical Endocrinology & Metabolism	2000	190

Page 1